[Chemotherapy of malignant melanoma].
D000477:Alkylating Agents / Q000627:therapeutic use; D000577:Amides / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D003510:Cyclohexanes / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy*; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy*; D014226:Triazenes / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000577:Amides; D000970:Antineoplastic Agents; D003510:Cyclohexanes; D007093:Imidazoles; D009607:Nitrosourea Compounds; D014226:Triazenes; D001761:Bleomycin; D014750:Vincristine; D002330:Carmustine; D006918:Hydroxyurea
Chimiothérapie du mélanome malin.